Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi loses bid to ditch U.S. suit on failed drug
Reuters
Friday, April 1, 2011 - 11:29am
tags:
Sanofi, lawsuits, Acomplia
Fund sues Cephalon as Valeant hints at higher bid
Fierce Pharma
Friday, April 1, 2011 - 11:20am
tags:
Cephalon, Valeant Pharmaceuticals, M&A
Charles River CEO no bonus for 2nd year
Bizjournals.com
Friday, April 1, 2011 - 11:18am
tags:
executive pay, Charles River Laboratories
Biotech Stock Mailbag: Avanir Pharma
TheStreet.com
Friday, April 1, 2011 - 10:08am
tags:
Avanir, Alexza, Somaxon, Pharmasset, Radient Pharmaceuticals, RXi Pharmaceuticals
RXi Pharmaceuticals Deal Promises Huge Upside
Seeking Alpha
Friday, April 1, 2011 - 9:49am
tags:
RXi Pharmaceuticals
Report: Antibiotic pipeline woefully thin
Fierce Biotech
Friday, April 1, 2011 - 9:46am
tags:
antibiotics
After Japan Crisis, New Urgency for Radiation Drugs
NY Times, NY
Friday, April 1, 2011 - 9:10am
tags:
radiation, Japan
Dividend Sector Review: Pharmaceuticals
Motley Fool
Thursday, March 31, 2011 - 10:15pm
tags:
dividends, Eli Lilly, GSK, AstraZeneca, Roche, Merck, Novartis, Abbott Laboratories, Pfizer, JNJ
Omeros says knee drug didn't meet goal in ACL surgery study, shares plunge after hours
Yahoo/AP
Thursday, March 31, 2011 - 10:13pm
tags:
ACL surgery, Omeros, OMS103HP
Better Buy? Seattle Genetics or ImmunoGen
Motley Fool
Thursday, March 31, 2011 - 6:59pm
tags:
Immunogen, Seattle Genetics
J&J Loses Bid to Overturn $482 Million Patent Verdict
Bloomberg
Thursday, March 31, 2011 - 6:57pm
tags:
patents, JNJ
Peering Into Pfizer’s Future
Forbes
Thursday, March 31, 2011 - 6:56pm
tags:
Pfizer, generics, Lipitor
Biotech Fever Spreads
Forbes
Thursday, March 31, 2011 - 12:30pm
tags:
biotech, Cephalon, Dendreon, Celgene, Human Genome Sciences
BioSante's Potential Blockbuster Treatment
Seeking Alpha
Thursday, March 31, 2011 - 12:29pm
tags:
BioSante, LibiGel, female sexual dysfunction, Boehringer Ingelheim, Warner Chilcott
Vertex Pharmaceuticals' potential hepatitis C treatment meets safety goal in midstage study
Yahoo/AP
Thursday, March 31, 2011 - 12:27pm
tags:
hepatitis C, Vertex Pharmaceuticals, VX-222
Pharmasset Hepatitis C Drug Combination Helped 98% of Patients
Bloomberg
Thursday, March 31, 2011 - 12:25pm
tags:
hepatitis C, Phamasset, PSI-7977
Valeant's Surprise Bid for Cephalon: Repeating a Growth Trick?
Seeking Alpha
Thursday, March 31, 2011 - 11:56am
tags:
M&A, Cephalon, Valeant Pharmaceuticals
Major FDA Approval Could Pave the Way for These 5 Biotechs
Seeking Alpha
Thursday, March 31, 2011 - 11:55am
tags:
FDA, rindopepimut, brain cancer, Celldex, Geron, AML, GRNVAC1, blinatumomab, Micromet, non-Hodgkin's lymphoma, acute lymphoblastic leukemia, Oncothyreon, Stimuvax, breast cancer, lung cancer, Allovectin-7, Vical, melanoma
Gilead's Long-Term Cancer Fight
Motley Fool
Thursday, March 31, 2011 - 11:51am
tags:
Gilead Sciences, cancer
FDA fast-tracks Nile Therapeutics drug
Bizjournals.com
Thursday, March 31, 2011 - 11:00am
tags:
FDA, fast track, cenderitide, Nile Therapeutics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.